Compare Ginkgo Bioworks Holdings Inc (DNA) vs Consumer Discretionary Select Sector SPDR Fund (XLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while Consumer Discretionary Select Sector SPDR Fund trades at $112.85 (market cap $21.89B). The key difference: Consumer Discretionary Select Sector SPDR Fund is far larger — about 28.7× Ginkgo Bioworks Holdings Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Consumer Discretionary Select Sector SPDR Fund for 114 Days on average.
| DNA | XLY | |
|---|---|---|
Market Cap | $763.64M | $21.89B |
Volume | 3,204,177 | 5,690,342 |
Sector | Health | — |
52-Week High | $15.83 | $124.52 |
52-Week Low | $5.48 | $105.64 |
Typical Hold Time | 7 Days | 114 Days |
Enterprise Value | $865.59M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day. The technical outlook is bullish based on moving averages, while oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with a negative net income margin of -219.6%. Recent news includes a partnership with TuneLab and a $17.5 million ARPA-H subcontract.
The outlook is challenged by persistent losses and negative cash flow, though strategic partnerships offer growth potential. Analyst sentiment is divided evenly between buy, hold, and sell ratings. Key risks include execution on profitability and high cash burn. The stock presents a speculative opportunity dependent on the company's ability to monetize its technology platform.
XLY trades at $111.70 with a modest 0.31% daily gain, showing stability amid mixed technical signals. The ETF maintains a bullish overall technical rating despite underperforming consumer staples peers year-to-date. Analyst consensus remains unanimously positive with 100% buy ratings, though recent news highlights concerns about persistent underperformance versus the S&P 500 and inflationary pressures on consumer discretionary spending.
The outlook for XLY hinges on consumer resilience amid inflation, with potential catalysts from holiday sales growth and 'funflation' trends. Key risks include continued market underperformance and sensitivity to economic cycles. Institutional sentiment appears cautiously optimistic given the concentrated buy ratings, though technical indicators suggest near-term consolidation around current price levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Consumer Discretionary Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.
Read more on XLY →
